Commercial Information Circulars

24-hour hotline : 23 922 922

e-mail address : enquiry@tid.gov.hk

Ref. : EIC 631/2/5

24 November 2016

Dear Sirs,

Commercial Information Circular No. 880/2016

The Mainland of China : Notice Concerning "Application Materials and Requirement of the Formula Registration for Infant and Follow-up Formula (Trial)" and "On-Site Examination Points and Decision Criteria for the Formula Registration for Infant and Follow-up Formula (Trial)"

The China Food and Drug Administration (CFDA) of the People's Republic of China issued on 29 October 2016 a notice concerning "Application Materials and Requirement of the Formula Registration for Infant and Follow-up Formula (Trial)" and "On-Site Examination Points and Decision Criteria for the Formula Registration for Infant and Follow-up Formula (Trial)", which took effect on the date of promulgation. The Notice (available in Chinese only) can be downloaded from the website of CFDA at: http://www.sda.gov.cn/WS01/CL0087/166343.html

ENQUIRIES

2.If you have any questions on the content of the document mentioned in this circular, please contact the issuing authority of the Mainland of China direct. For other questions on this circular, please contact Mainland Branch (I) (tel: 2398 5444) of the Department.

Yours faithfully,

(Ms Helen CHENG)
for Director-General of Trade and Industry

Note: While every effort is made to ensure the accuracy of the above information, the Department cannot guarantee this to be so and will not be held liable for any reliance placed on the same.